BioSpace News Archive

Press Releases

Coya Therapeutics Announces Positive Results of a Double-Blind Study of Subcutaneous Low-Dose Interleukin-2 (LD IL-2) in Alzheimer’s Disease (AD) Presented at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24) in Madrid (Spain)

October 29, 2024
·
18 min read
Press Releases

GlycoMimetics Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint

October 29, 2024
·
2 min read
Press Releases

BioXcel Therapeutics to Present at ThinkEquity Conference

October 29, 2024
·
5 min read
Press Releases

Sagimet Biosciences Announces Successful Completion of End-of-Phase 2 Interactions with FDA on the Development of Denifanstat for MASH; Phase 3 Program Initiation Expected by End of 2024

October 29, 2024
·
6 min read
Press Releases

Owkin Announces MSIntuit® CRC v2, a Next-Generation AI Diagnostic Aimed at Transforming the Detection and Treatment of Colorectal Cancer

October 29, 2024
·
3 min read
Press Releases

Curis Announces $12.1 Million Registered Direct and Concurrent Private Placement

October 29, 2024
·
6 min read
Experic Announces Growth Capital Investment Led by 1315 Capital

October 29, 2024
·
2 min read
Press Releases

Medigene to Present at Upcoming November 2024 Investor Conferences

October 29, 2024
·
2 min read
Press Releases

Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024

October 29, 2024
·
1 min read
Press Releases

BioStem Technologies Initiates Nationwide Launch of Vendaje AC® with Venture Medical Following Established Reimbursement in All Medicare Administrative Contractor (MAC) Regions

October 29, 2024
·
6 min read